AML - acute myeloid leukemia
Clinical trials for AML - acute myeloid leukemia explained in plain language.
Never miss a new study
Get alerted when new AML - acute myeloid leukemia trials appear
Sign up with your email to follow new studies for AML - acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control CancelledThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goals are to check safety and see if it can prevent the cancer from coming …
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase 1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough childhood leukemia
Disease control CancelledThis early-phase study tests a new treatment called CLL-1 CAR-T for children aged 3 to 18 with acute myeloid leukemia that has come back or not responded to standard therapy. Ten participants will receive an infusion of their own modified immune cells after chemotherapy. The main…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Early phase 1 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a common steroid make AML treatment easier to tolerate?
Disease control By invitation onlyThis early-phase study tests whether adding the steroid dexamethasone to standard low-intensity chemotherapy is safe and tolerable for adults newly diagnosed with acute myeloid leukemia (AML) who cannot have intensive chemo. About 20 participants will receive the combination over…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase 1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC